Amalgamated Bank Has $1.62 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Amalgamated Bank lowered its stake in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 2.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,597 shares of the company’s stock after selling 571 shares during the period. Amalgamated Bank’s holdings in Henry Schein were worth $1,616,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in HSIC. Palestra Capital Management LLC acquired a new stake in Henry Schein in the fourth quarter valued at approximately $182,988,000. Lyrical Asset Management LP acquired a new stake in Henry Schein in the fourth quarter valued at approximately $126,655,000. Norges Bank acquired a new stake in Henry Schein in the fourth quarter valued at approximately $103,301,000. Steadfast Capital Management LP boosted its position in Henry Schein by 254.2% in the fourth quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock valued at $113,336,000 after buying an additional 1,175,408 shares in the last quarter. Finally, Hudson Bay Capital Management LP boosted its position in Henry Schein by 102.1% in the fourth quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company’s stock valued at $101,378,000 after buying an additional 740,007 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $74.67 on Monday. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The firm has a fifty day simple moving average of $70.70 and a 200 day simple moving average of $71.20. The company has a market capitalization of $9.09 billion, a PE ratio of 23.33, a P/E/G ratio of 2.41 and a beta of 0.87. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter last year, the firm earned $1.10 earnings per share. Henry Schein’s quarterly revenue was down .1% on a year-over-year basis. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on HSIC. Piper Sandler cut their price target on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a report on Wednesday, April 30th. Wall Street Zen lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Wells Fargo & Company cut their price target on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Finally, Barrington Research cut their price target on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating on the stock in a report on Tuesday, May 6th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and a consensus price target of $79.30.

Check Out Our Latest Stock Analysis on Henry Schein

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.